Emory researchers studying psychedelic-assisted treatment for PTSD
Atlanta university’s study comes as FDA evaluates treating disorder with MDMA, a psychedelic drug also known as ecstasy.
Link to full article. Excerpt:
Before it voted, the FDA’s advisory panel heard from many proponents, including some of Lykos’ study trial participants. Among them was Cristina Pearse, a Colorado resident who leads a nonprofit organization focused on helping women recover from trauma. Pearse told the panel she was sexually assaulted as a young child and was diagnosed with PTSD when she was 45.
“I nearly died from PTSD — this trial saved my life,” she told The Atlanta Journal-Constitution. “All of my work now underscores the fact that I believe this therapy works. The FDA advisory committee is wrong. We need it now for those whose life also hangs in the balance. It will save lives.”
